Zackery P. Bulman
Assistant Professor, College of Pharmacy - Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Research Interests:
The medical community is at a constant state of war with bacteria to both prevent and overcome antimicrobial resistance, which is one of the largest threats to global health. The frequency and nature of bacterial cell replication combined with the widespread use of antibiotics suggests that antimicrobial resistance is likely to persist. Dr. Bulman’s laboratory investigates novel pharmacotherapeutic approaches that aim to overcome drug resistant bacteria and improve patient outcomes.
Teaching and Supervision Heading link
Undergrad Resrch Pharm Pract (PMPR 380), 1/10/2022 – 4/29/2022
Applied Research Methods (PMPR 376), 1/10/2022 – 4/29/2022
Pathophysiology, Drug Action, & Therapeutics (PDAT) 6: Infectious Diseases (PHAR 506), 1/1/2022 – 5/6/2022
Pharmacokinetics (PHAR 435), 8/23/2021 – 12/3/2021
Pharmacokinetics (PHAR 435), 8/23/2021 – 12/3/2021
Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 4/30/2021
Spec Topics in Pharm Pract (PMPR 385), 1/11/2021 – 4/30/2021
Case Based Infectious Diseases (PMPR 349), 1/1/2021 – 5/7/2021
Pathophysiology, Drug Action, & Therapeutics (PDAT) 6: Infectious Diseases (PHAR 506), 1/1/2021 – 5/7/2021
Selected Grants
EBL-1003 for the treatment of NTM infections in CF patients, Juvabis AG., 6/18/2022 - 5/31/2023, Obligated Amount: $42210; Anticipated Amount: $42210
Selected Publications
Huang, Yanqin, Rana, Amisha P, Wenzler, Eric, Ozer, Egon A, Krapp, Fiorella, Bulitta, Jürgen B, Hauser, Alan R, Bulman, Zackery P. (2021). Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.. Journal of Antimicrobial Chemotherapy, 77, (2), 356-363. doi:10.1093/jac/dkab381.
Bulman, Zackery P, Krapp, Fiorella, Pincus, Nathan B, Wenzler, Eric, Murphy, Katherine R, Qi, Chao, Ozer, Egon A, Hauser, Alan R. (2021). Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae. mSystems, 6, (5), e00194-e00121. doi:10.1128/msystems.00194-21.
Huang, Yanqin, Sokolowski, Karol, Rana, Amisha, Singh, Nidhi, Wang, Jiping, Chen, Ke, Lang, Yinzhi, Zhou, Jieqiang, Kadiyala, Neera, Krapp, Fiorella, Ozer, Egon A, Hauser, Alan R, Li, Jian, Bulitta, Jürgen B, Bulman, Zackery P. (2021). Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 65, (9), e00692-e00621. doi:10.1128/aac.00692-21.
McMurtry, Tiffany A, Barekat, Ayeh, Rodriguez, Fantasia, Purewal, Parwinder, Bulman, Zackery P, Lenhard, Justin R. (2021). Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.. Journal of Antimicrobial Chemotherapy, 76, (10), 2610-2614. doi:10.1093/jac/dkab211.
Huang, Yanqin, Wu, Tiffany, Perez, Omar, Rana, Amisha P, Chen, Liang, Kreiswirth, Barry N, Satlin, Michael J, Bulman, Zackery P. (2021). In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae. Frontiers in Microbiology, 12, 618087. doi:10.3389/fmicb.2021.618087.
Tan, Xing, Kim, Hwan Seung, Baugh, Kimberly, Huang, Yanqin, Kadiyala, Neeraja, Wences, Marisol, Singh, Nidhi, Wenzler, Eric, Bulman, Zackery P. (2021). Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales. Infection and Drug Resistance, 14, 125-142. doi:10.2147/idr.s246174.
Biagi, M, Lamm, D, Meyer, K, Vialichka, A, Jurkovic, M, Patel, S, Mendes, RE, Bulman, ZP, Wenzler, E. (2020). Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.. Antimicrobial Agents and Chemotherapy, 64, (12). doi:10.1128/aac.00297-20.
Bulman, Zackery P, Cirz, Ryan, Hildebrandt, Darin, Kane, Tim, Rosario, Zuelay, Wlasichuk, Ken, Park, Minjong, Andrews, Logan D. (2020). Unraveling the Gentamicin Drug Product Complexity Reveals Variation in Microbiological Activities and Nephrotoxicity.. Antimicrobial Agents and Chemotherapy, 64, (9). doi:10.1128/aac.00533-20.
Tan, X, Baugh, K, Bulman, ZP, Wenzler, E. (2020). Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species. Current Fungal Infection Reports, 14, (3), 268-278. doi:10.1007/s12281-020-00388-1.
Professional Leadership
ACCP ID PRN Nominations Committee, American College of Clinical Pharmacy, 1/1/2022 - 12/31/2022
SIDP Website Committee, Society for Infectious Diseases Pharmacists, 11/1/2021 - 10/31/2022
PhD Thesis External Reviewer, 6/18/2021 - 8/31/2021
ISAC Anti-Infective Pharmacology Working Group, 12/2/2019 - Present
SIDP Website Committee, 11/25/2019 - 10/29/2021
ISAP Treasurer, International Society of Anti-Infective Pharmacology, 2018 - Present
Notable Honors
2022, ACCP RI Student Futures Grant Mentor, American College of Clinical Pharmacy
2020, FISAC, International Society of Antimicrobial Chemotherapy
2020, Hans W. Vahlteich Research Scholar,
2018, ACCP RI Student Futures Grant Mentor, American College of Clinical Pharmacy
2016, IDWeek Trainee Award, Infectious Diseases Society of America
2016, ASM Microbe Travel Award, American Society for Microbiology
2015, ICAAC Infectious Diseases Fellows Grant, American Society for Microbiology
2015, Wolters Kluwer Award for Scientific Communication, School of Pharmacy
2015, Daniel H. Murray Memorial Professional Development Award, Daniel H. Murray Memorial
Education
Degrees:
PharmD, University at Buffalo, State University of New York, United States, 2015
B.S., Rochester Institute of Technology, United States, 2011
Postgraduate Training:
Infectious Diseases Pharmacology Fellowship, University at Buffalo, State University of New York, United States, 2017
Clinical and Translational Research Fellow, VA Western New York Healthcare System, United States, 2017
Selected Presentations
Singh, Nidhi, Poggensee, Linda, Huang, Yanqin, Evans, Charlesnika T, Suda, Katie J, Bulman, Zackery P. (2022 May 03). Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020. doi:10.1093/jacamr/dlac049.
Bulman, Zackery. (2021 December 17). Genotype specific combination treatment strategies to thwart KPC-producing K. pneumoniae. Antimicrobial Resistance Symposium. Beijing, China [Virtual Seminar].
Bulman, Zackery, Rao, Gauri, Velkov, Tony. (2021 November 05). Meet the Editors: Zackery Bulman, Gauri Rao, and Tony Velkov. Chinese Agricultural University Infectious Diseases Symposium. Beijing, China [Virtual Seminar].
Dudley, Mike, Bulman, Zackery, Rao, Gauri. (2021 October 26). It Takes Two to Tango: PK-PD Considerations for Beta-lactamase Inhibitor Combinations for Drug Resistant Pathogens. Anti-Infective Working Group Seminar Series.